What is the catalog number for VEGFC Antibody [APR04570G]?

The catalog number for VEGFC Antibody [APR04570G] is APR04570G.

What sizes are available for VEGFC Antibody [APR04570G]?

VEGFC Antibody [APR04570G] is available in the following size(s): 50 µL, 100 µL, 200 µL, 400 µL.

How many pack sizes does VEGFC Antibody [APR04570G] come in?

VEGFC Antibody [APR04570G] is available in 4 different pack sizes.

Is VEGFC Antibody [APR04570G] in stock?

VEGFC Antibody [APR04570G] is currently made to order / not held in immediate stock. Contact us for lead time.

VEGFC Antibody [APR04570G]

Product Specifications

Background

Tissue Location: Spleen, lymph node, thymus, appendix, bone marrow, heart, placenta, ovary, skeletal muscle, prostate, testis, colon and small intestine and fetal liver, lung and kidney, but not in peripheral blood lymphocyte

Overview

We constantly strive to ensure we provide our customers with the best antibodies. As a result of this work we offer this antibody in purified format. We are in the process of updating our datasheets. If you have any questions regarding this update, please feel free to contact our technical support team. This product is a high quality VEGFC Antibody [APR04570G].

Synonyms

Vascular endothelial growth factor C, VEGF-C, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VRP, VEGFC

Gene Name

VEGFC

Gene ID

7424

UniProt

P49767

Chromosomal Location

Secreted.

Applications

WB, FC

Dilution

FC--1:25 WB--1:2000

Form

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.

Function

Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates KDR/VEGFR2 and FLT4/VEGFR3 receptors.